Predicted protein targets (top 1)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ACKR3 | P25106 | 20/20 | 0.60 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5577036 | 1.00 | ACKR3 (0.60) | ACKR3 | |
| SCHEMBL4754831 | 0.92 | ACKR3 (0.60) | ACKR3 | |
| SCHEMBL14601241 | 0.92 | ACKR3 (0.60) | ACKR3 | |
| SCHEMBL14601242 | 0.90 | ACKR3 (0.56) | ACKR3 | |
| SCHEMBL14639976 | 0.90 | ACKR3 (0.55) | ACKR3 | |
| SCHEMBL14601238 | 0.90 | ACKR3 (0.55) | ACKR3 | |
| SCHEMBL13316398 | 0.87 | ACKR3 (0.63) | ACKR3 | |
| SCHEMBL13316357 | 0.87 | ACKR3 (0.63) | ACKR3 | |
| SCHEMBL3541498 | 0.86 | ACKR3 (0.64) | ACKR3 | |
| SCHEMBL13316410 | 0.86 | ACKR3 (0.64) | ACKR3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20070021484-A1 | Substituted N-cinnamyl benzamides | CHEMOCENTRYX, INC. (US) | 2007-01-25 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070021484-A1 | Substituted N-cinnamyl benzamides | BRDT, BCCIP, NAT10 | ACKR3 4393/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.